Loss of CADM4 expression is associated with poor prognosis in small intestinal adenocarcinomas.

about

Loss of CADM4 expression is associated with poor prognosis in small intestinal adenocarcinomas.

Item

http://www.wikidata.org/entity/Q51034305

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Loss of CADM4 expression is as ...... ll intestinal adenocarcinomas.

@en

Loss of CADM4 expression is as ...... ll intestinal adenocarcinomas.

@nl

type

Item

label

Loss of CADM4 expression is as ...... ll intestinal adenocarcinomas.

@en

Loss of CADM4 expression is as ...... ll intestinal adenocarcinomas.

@nl

prefLabel

Loss of CADM4 expression is as ...... ll intestinal adenocarcinomas.

@en

Loss of CADM4 expression is as ...... ll intestinal adenocarcinomas.

@nl

P1476

Loss of CADM4 expression is as ...... ll intestinal adenocarcinomas.

@en

P2093

Jung Yeon Kim

http://www.w3.org/2001/XMLSchema#string

Kyung-Ju Kim

http://www.w3.org/2001/XMLSchema#string

Mi Jin Gu

http://www.w3.org/2001/XMLSchema#string

P2860

Isolation of the TSLL1 and TSLL2 genes, members of the tumor suppressor TSLC1 gene family encoding transmembrane proteins.

Isolation of the mouse Tsll1 and Tsll2 genes, orthologues of the human TSLC1-like genes 1 and 2 (TSLL1 and TSLL2).

An insight into the genetic pathway of adenocarcinoma of the small intestine

The Cell Adhesion Molecule Necl-4/CADM4 Serves as a Novel Regulator for Contact Inhibition of Cell Movement and Proliferation.

Cancer treatment and survivorship statistics, 2016.

SynCAM, a novel putative tumor suppressor, suppresses growth and invasiveness of glioblastoma.

Aberrations of a cell adhesion molecule CADM4 in renal clear cell carcinoma.

Cell adhesion and prostate tumor-suppressor activity of TSLL2/IGSF4C, an immunoglobulin superfamily molecule homologous to TSLC1/IGSF4.

Clinicopathologic and prognostic associations of KRAS and BRAF mutations in small intestinal adenocarcinoma.

Adenocarcinoma of the small intestine: a multi-institutional study of 197 surgically resected cases.

P304

437-443

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/APM.12684

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

125

http://www.w3.org/2001/XMLSchema#string

P50

Seung-Mo Hong

P577

2017-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28444978

http://www.w3.org/2001/XMLSchema#string